Drug for preventing and/or treating polycystic kidney disease
AssigneeOtsuka Pharmaceutical Co., Ltd.
InventorsHiroyuki Fujiki, Miki Aihara, Shizuo Kinoshita
Life of this patent
Estimating the term…
Abstract
An object of the present invention is to provide a combination drug that has remarkably excellent preventive and/or therapeutic effects on polycystic kidney disease. The present invention provides a drug for preventing and/or treating polycystic kidney disease comprising a combination of tolvaptan or a prodrug thereof with a somatostatin derivative, and a method for treating polycystic kidney disease using this drug.
Claims3
A combination for suppressing progression of polycystic kidney disease and/or treating polycystic kidney disease, wherein said combination comprises a synergistically effective amount of a sustained-release formulation of tolvaptan or a prodrug thereof, and a sustained-release formulation of vapreotide or a salt thereof.
A kit for suppressing disease progression of polycystic kidney disease and/or treating polycystic kidney disease, wherein said kit comprises a synergistically effective amount of an oral sustained-release formulation of tolvaptan or a prodrug thereof, and an injectable sustained-release formulation of vapreotide or a salt thereof.
Dependencies are inferred from the claim text.